Pharmacokinetics of the generic formulation Propofol 1% Fresenius in comparison with the original formulation (Disoprivan® 1%)

Clinical Drug Investigation

Volumn 22, Issue 7, 2002, Pages 417-427

  Jungheinrich, Cornelius ^a   Scharpf, Roland ^a   Wargenau, Manfred ^b   Dilger, Carmen ^c   Bepperling, Frank ^a  

^a Fresenius Kabi Deutschland GmbH   (Germany)

^b MARCO Biostatistics Institute   (Germany)

^c AAI Deutschland GmbH and Co KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; PROPOFOL;

ADULT; ARTICLE; BIOEQUIVALENCE; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG FORMULATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; REFERENCE VALUE; VALIDATION PROCESS;

EID: 0036066893     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200222070-00001     Document Type: Article

References (22)

1. Effects of propofol on sodium channel-dependent sodium influx and glutamate release in rat cerebrocortical synaptosomes
2. Interactions of intravenous anaesthetics with human CNS ion channels: Electrophysiologic investigations using a novel voltage-clamp technique
3. Comparison of the reinforcing effects of propofol and methohexital in baboons
4. General anaesthetics and their effects on GABA(A) receptor desensitization
5. Effects of intravenous anesthetic agents on glutamate release
6. Correlating in vivo anaesthetic effects with ex vivo receptor density data supports GABAergic mechanism of action for propofol, but not for isoflurane
7. Investigations into pharmacological antagonism of general anaesthesia
8. New IV drugs
9. Pharmacokinetic implications for the clinical use of propofol
10. Propofol: An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation
11. Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol
12. Gender differences in the pharmacokinetlcs of propofol in elderly patients during and after continuous infusion
13. Pharmacokinetics and pharmacodynamics of propofol infusions during general anaesthesia
14. Pharmacokinetics of propofol ('Diprivan') as an induction agent
15. Pharmacokinetics of propofol in female patients: Studies using single bolus injections
16. The pharmacokinetics of propofol during and after intravenous infusion in man
17. Common variation in the lipoprotein lipase gene: Effects on plasma lipids and risk of atherosclerosis
18. A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: The Framingham Offspring Study
19. Structure and metabolic fate of triacylglycerol- and phospholipid-rich particles of commercial parenteral fat emulsions
20. Chylomicron clearance in normal and hyperlipidemic man
21. Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase
22. Comparative study of propofol emulsions for anesthesia in varicose vein operations